The authors discuss future perspectives of early-cancer detection and clonal hematopoiesis filtering strategies, with possible inclusion of microbiome-driven liquid biopsy.
[Molecular Oncology]
7753456 IQ4GJHPR items 1 apa 0 default asc 1 162975 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-c3085fe117b6e204107c486b72c3d16c%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22IQ4GJHPR%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Filipska%20and%20Rosell%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFilipska%2C%20M.%2C%20%26amp%3B%20Rosell%2C%20R.%20%282021%29.%20Mutated%20circulating%20tumor%20DNA%20as%20a%20liquid%20biopsy%20in%20lung%20cancer%20detection%20and%20treatment.%20%3Ci%3EMolecular%20Oncology%3C%5C%2Fi%3E%2C%20%3Ci%3E15%3C%5C%2Fi%3E%286%29%2C%201667%26%23x2013%3B1682.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2Fhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2F1878-0261.12983%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2Fhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2F1878-0261.12983%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3DIQ4GJHPR%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mutated%20circulating%20tumor%20DNA%20as%20a%20liquid%20biopsy%20in%20lung%20cancer%20detection%20and%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martyna%22%2C%22lastName%22%3A%22Filipska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rafael%22%2C%22lastName%22%3A%22Rosell%22%7D%5D%2C%22abstractNote%22%3A%22Over%20the%20past%20decade%2C%20substantial%20developments%20have%20been%20made%20in%20the%20detection%20of%20circulating%20tumor%20DNA%20%28ctDNA%29%5Cu2014cell-free%20DNA%20%28cfDNA%29%20fragments%20released%20into%20the%20circulation%20from%20tumor%20cells%20and%20displaying%20the%20genetic%20alterations%20of%20those%20cells.%20As%20such%2C%20ctDNA%20detected%20in%20liquid%20biopsies%20serves%20as%20a%20powerful%20tool%20for%20cancer%20patient%20stratification%2C%20therapy%20guidance%2C%20detection%20of%20resistance%2C%20and%20relapse%20monitoring.%20In%20this%20Review%2C%20we%20describe%20lung%20cancer%20diagnosis%20and%20monitoring%20strategies%20using%20ctDNA%20detection%20technologies%20and%20compile%20recent%20evidence%20regarding%20lung%20cancer-related%20mutation%20detection%20in%20liquid%20biopsy.%20We%20focus%20not%20only%20on%20epidermal%20growth%20factor%20receptor%20%28EGFR%29%20alterations%2C%20but%20also%20on%20significant%20co-mutations%20that%20shed%20more%20light%20on%20novel%20ctDNA-based%20liquid%20biopsy%20applications.%20Finally%2C%20we%20discuss%20future%20perspectives%20of%20early-cancer%20detection%20and%20clonal%20hematopoiesis%20filtering%20strategies%2C%20with%20possible%20inclusion%20of%20microbiome-driven%20liquid%20biopsy.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2F1878-0261.12983%22%2C%22ISSN%22%3A%221878-0261%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ffebs.onlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2F1878-0261.12983%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%2243ZBJFKZ%22%5D%2C%22dateModified%22%3A%222021-06-03T19%3A06%3A14Z%22%7D%7D%5D%7D
Filipska, M., & Rosell, R. (2021). Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment. Molecular Oncology, 15(6), 1667–1682. https://doi.org/https://doi.org/10.1002/1878-0261.12983 Cite